文献速递性腺与生殖内分泌

Klinefelter综合征中MAP-1升高与凝集素补体激活能力增强

Increased MAP-1 and lectin complement activation capacity in Klinefelter syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究为横断面研究,比较45例Klinefelter综合征(KS)男性与45例年龄匹配对照,发现KS患者凝集素途径补体激活能力显著升高(106.2±51.6% vs 64.0±30.1%,P<.0001),血清MAP-1水平和MASP1-201表达亦升高,提示免疫调节异常可能是KS特有特征并贡献于其共病负担。

要点

  • KS男性凝集素补体途径激活能力显著高于年龄匹配对照。
  • KS患者血清MAP-1水平及骨骼肌MASP1-201表达升高。
  • 凝集素途径与KS纤溶 clot 溶解变异性相关,但与性激素关联不强。

核心结论

  • KS男性存在凝集素补体途径激活能力增强,伴MAP-1和MASP1-201表达升高,免疫功能改变可能是KS特异性特征并贡献于其共病负担。

研究设计与样本

  • 横断面研究,比较45例KS男性与45例年龄匹配男性对照。

主要发现

  • KS组凝集素途径激活能力为106.2±51.6%,对照组为64.0±30.1%,P<.0001。
  • KS患者血清MAP-1水平升高,骨骼肌MASP1-201表达增加。
  • 血清C3dg水平在KS与对照间无差异。
  • 凝集素途径激活能力与性激素水平关联不强,与体脂仅弱相关。
  • 凝集素途径贡献于KS纤溶 clot 溶解变异性,纤维蛋白原-C3dg复合物水平两组相似。

临床怎么用

  • 对KS患者评估免疫紊乱与补体激活可能有助于理解其共病风险,但尚不推荐常规检测。

局限性

  • 横断面设计无法推断因果关系,样本量有限,未报告多变量校正或混杂因素控制细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Klinefelter syndrome (KS) is a congenital condition linked to immune dysregulation and metabolic dysfunction with an increased risk of autoimmune, metabolic, and cardiovascular diseases. OBJECTIVE: We examined complement activation through the lectin pathway in men with KS and its relationships with hypogonadism, body composition, and fibrinolytic function. METHODS: We conducted a cross-sectional study comparing men with KS with age-matched controls. We measured lectin pathway complement activation capacity, individual lectin complement factors including the lectin pathway regulator MAP-1, and the main complement split product, C3dg, using ELISAs. Body composition was assessed by dual-energy X-ray absorptiometry, and fibrin clot lysis was analyzed via turbidometry. Additionally, we analyzed skeletal muscle mRNA expression of the MASP1 gene splice variant MASP1-201, which encodes MAP-1. RESULTS: Lectin pathway activation capacity was higher in 45 men with KS compared to 45 male controls (mean ± SD, 106.2 ± 51.6% vs 64.0 ± 30.1%, P < .0001). Serum MAP-1 levels were also elevated in KS patients. MASP1-201 expression was increased in KS. Serum C3dg levels were not different between KS and controls. The lectin pathway activation capacity was not strongly linked to sex hormone levels and only had a weak association with body fat. The lectin pathway contributed to fibrin clot lysis variability in KS, and levels of the fibrinogen-C3dg complex were similar in both KS and controls. CONCLUSION: Men with KS demonstrate increased lectin complement pathway activation capacity, and increased MAP-1 and MASP1-201 expression. Altered immune function could be a specific characteristic of KS contributing to the comorbidity burden.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chang S, Just J, Skakkebæk A, et al. Increased MAP-1 and lectin complement activation capacity in Klinefelter syndrome. J Clin Endocrinol Metab. 2026. PMID: 41873701. doi:10.1210/clinem/dgag129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。